$INBP
INTEGRATED BIOPHARMA INC Stock $inbp

$inbp Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000143774924029768 Filed on September 20, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$13.62M	$12.75M	$50.32M
YoY Change	5.44%	-1.88%	-0.7%
Cost Of Revenue	$12.25M	$11.46M	$46.43M
YoY Change	1.35%	-4.56%	-0.38%
Gross Profit	$1.371M	$1.284M	$3.884M
YoY Change	64.78%	29.7%	-4.36%
Gross Profit Margin	10.07%	10.07%	7.72%
Selling, General & Admin	$881.0K	$882.0K	$3.633M
YoY Change	-0.56%	-3.08%	-7.82%
% of Gross Profit	64.26%	68.69%	93.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$88.00K	$87.00K	$319.0K
YoY Change	14.29%	8.75%	-9.12%
% of Gross Profit	6.42%	6.78%	8.21%
Operating Expenses	$881.0K	$882.0K	$3.633M
YoY Change	-0.56%	-3.08%	-7.82%
Operating Profit	$490.0K	$402.0K	$251.0K
YoY Change	-1007.41%	402.5%	109.17%
Interest Expense	$14.00K	$12.00K	$52.00K
YoY Change	-275.0%	-220.0%	0.0%
% of Operating Profit	2.86%	2.99%	20.72%
Other Income/Expense, Net		$0.00	$17.00K
YoY Change		-100.0%	-185.0%
Pretax Income	$504.0K	$414.0K	$268.0K
YoY Change	-1195.65%	417.5%	168.0%
Income Tax	$245.0K	$146.0K	$156.0K
% Of Pretax Income	48.61%	35.27%	58.21%
Net Earnings	$259.0K	$268.0K	$112.0K
YoY Change	-538.98%	570.0%	-429.41%
Net Earnings / Revenue	1.9%	2.1%	0.22%
Basic Earnings Per Share	$0.01		$0.00
Diluted Earnings Per Share	$0.01	$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	30.10M	30.10M	30.07M
Diluted Shares Outstanding	30.65M		30.87M

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.271M	$1.677M	$1.677M
YoY Change	-12.32%	27.05%	27.05%
Cash & Equivalents	$2.271M	$1.677M
Short-Term Investments
Other Short-Term Assets	$432.0K	$286.0K	$286.0K
YoY Change	-10.37%	0.7%	2.14%
Inventory	$11.22M	$11.24M	$11.24M
Prepaid Expenses
Receivables	$4.385M	$4.668M	$4.668M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$18.31M	$17.88M	$17.88M
YoY Change	3.11%	9.18%	9.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.853M	$1.885M	$3.675M
YoY Change	13.26%	14.04%	-14.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.460M	$4.657M	$4.657M
YoY Change	-6.69%	-2.57%	-2.57%
Total Long-Term Assets	$7.871M	$8.332M	$8.332M
YoY Change	-11.39%	-8.03%	-8.04%
TOTAL ASSETS
Total Short-Term Assets	$18.31M	$17.88M	$17.88M
Total Long-Term Assets	$7.871M	$8.332M	$8.332M
Total Assets	$26.18M	$26.21M	$26.21M
YoY Change	-1.72%	3.05%	3.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.763M	$2.510M	$2.510M
YoY Change	-21.86%	10.77%	10.57%
Accrued Expenses	$3.266M	$3.606M	$3.606M
YoY Change	24.66%	43.1%	43.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$7.000K	$7.000K
YoY Change	-100.0%	-83.33%	-82.5%
Total Short-Term Liabilities	$6.029M	$6.123M	$6.123M
YoY Change	-2.71%	26.82%	26.77%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$604.0K	$846.0K	$846.0K
YoY Change	-61.28%	-51.38%	-51.38%
Total Long-Term Liabilities	$604.0K	$846.0K	$846.0K
YoY Change	-61.28%	11985.71%	-51.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.029M	$6.123M	$6.123M
Total Long-Term Liabilities	$604.0K	$846.0K	$846.0K
Total Liabilities	$6.633M	$6.969M	$6.969M
YoY Change	-14.48%	6.07%	6.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.97M	-$32.23M
YoY Change	-1.33%	-0.35%
Common Stock	$60.00K	$60.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.55M	$19.24M	$19.24M
YoY Change
Total Liabilities & Shareholders Equity	$26.18M	$26.21M	$26.21M
YoY Change	-1.72%	3.05%	3.06%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	$259.0K	$268.0K	$112.0K
YoY Change	-538.98%	570.0%	-429.41%
Depreciation, Depletion And Amortization	$88.00K	$87.00K	$319.0K
YoY Change	14.29%	8.75%	-9.12%
Cash From Operating Activities	$657.0K	-$186.0K	$943.0K
YoY Change	-49.96%	-84.37%	-23.46%
INVESTING ACTIVITIES
Capital Expenditures	$56.00K	$146.0K	$553.0K
YoY Change	47.37%	630.0%	376.72%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$56.00K	-$146.0K	-$553.0K
YoY Change	47.37%	630.0%	398.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$7.000K	-11.00K	-$29.00K
YoY Change	-333.33%	10.0%	-78.68%
NET CHANGE
Cash From Operating Activities	$657.0K	-186.0K	$943.0K
Cash From Investing Activities	-$56.00K	-146.0K	-$553.0K
Cash From Financing Activities	-$7.000K	-11.00K	-$29.00K
Net Change In Cash	$594.0K	-343.0K	$361.0K
YoY Change	-53.52%	-71.89%	-63.35%
FREE CASH FLOW
Cash From Operating Activities	$657.0K	-$186.0K	$943.0K
Capital Expenditures	$56.00K	$146.0K	$553.0K
Free Cash Flow	$601.0K	-$332.0K	$390.0K
YoY Change	-52.86%	-72.56%	-65.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.002
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.002
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30134510
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29984510
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30099610
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29949610
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	34900
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	34900
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2023Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-31668
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2407475
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	225 Long Ave.
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Hillside
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07205
CY2024	dei	City Area Code CityAreaCode	888
CY2024	dei	Local Phone Number LocalPhoneNumber	319-6962
CY2024	dei	Security12g Title Security12gTitle	Common Stock, $.002 par value per share
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	3367657	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30099610
CY2024	dei	Auditor Firm AuditorFirmId	688
CY2024	dei	Auditor Name AuditorName	Marcum LLP
CY2024	dei	Auditor Location AuditorLocation	East Hanover, New Jersey
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	50317000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	50672000	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46433000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46611000	usd
CY2024	us-gaap	Gross Profit GrossProfit	3884000	usd
CY2023	us-gaap	Gross Profit GrossProfit	4061000	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3633000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3941000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	251000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	120000	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	-18000	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	17000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	268000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	100000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	156000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-34000	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30066003
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29949610
CY2024	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	807678
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30873681
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29949610
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1677000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1316000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4668000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4511000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	11244000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	10261000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	286000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	284000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	17875000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	16372000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1885000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1653000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1790000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2623000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4601000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4726000	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	56000	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	57000	usd
CY2024Q2	us-gaap	Assets Assets	26207000	usd
CY2023Q2	us-gaap	Assets Assets	25431000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2510000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2266000	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2661000	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1632000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7000	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	42000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	945000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	888000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6123000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4828000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	846000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1735000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	6969000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	6570000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	60000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	60000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51504000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	51239000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32227000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32339000	usd
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	99000	usd
CY2023Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	99000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	19238000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18861000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26207000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25431000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18575000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	320000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-34000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18861000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	252000	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	19238000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	112000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-34000	usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	902000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	803000	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	319000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	351000	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	125000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	72000	usd
CY2024	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	12000	usd
CY2023	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	12000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	252000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	320000	usd
CY2024	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	27000	usd
CY2024	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-0	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-35000	usd
CY2024	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-36000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3000	usd
CY2024	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	120000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-374000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	983000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-794000	usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-34000	usd
CY2024	inbp	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-902000	usd
CY2023	inbp	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-804000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	244000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-921000	usd
CY2024	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1029000	usd
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	221000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	943000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1232000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	553000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	116000	usd
CY2024	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	4000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-553000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-111000	usd
CY2024	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	-0	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	101000	usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2024	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	35000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-136000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	361000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	985000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1316000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	331000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1677000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1316000	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	42000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	41000	usd
CY2024	us-gaap	Income Taxes Paid IncomeTaxesPaid	37000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	60000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1560000	usd
CY2024	inbp	Trade In Value On Likekind Exchanges TradeInValueOnLikekindExchanges	1000	usd
CY2023	inbp	Trade In Value On Likekind Exchanges TradeInValueOnLikekindExchanges	0	usd
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;"><b><i>Reclassifications. </i></b>Certain prior year amounts have been reclassified to conform to the current year presentation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;"><b><i>Use of Estimates.</i></b> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are <em style="font: inherit;">not</em> readily apparent from other sources. The most significant estimates include:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● sales returns and allowances;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● allowance for credit losses;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● inventory valuation;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● valuation and recoverability of long-lived assets;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● income taxes and valuation allowance on deferred income taxes, and;</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 18pt;">● accruals for, and the probability of, the outcome of current litigation, if any.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 18pt;">On a continual basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37000	usd
CY2008Q3	inbp	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.06	pure
CY2024	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-35000	usd
CY2024	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-0	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	27000	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	7888000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6859000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2449000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2148000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	907000	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1254000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	11244000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	10261000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9815000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9422000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7930000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7769000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1885000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1653000	usd
CY2024	us-gaap	Depreciation Depreciation	319000	usd
CY2023	us-gaap	Depreciation Depreciation	351000	usd
CY2024	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	12000	usd
CY2023	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	12000	usd
CY2024	us-gaap	Interest Expense InterestExpense	52000	usd
CY2023	us-gaap	Interest Expense InterestExpense	52000	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	61000	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	124000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	55000	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	18000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	156000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.256	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.746	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.211	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	1.66	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.616	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1.88	pure
CY2024	inbp	Effective Income Tax Rate Reconciliation Writeoff In Deferred Tax Assets Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationWriteoffInDeferredTaxAssetsValuationAllowancePercent	0.621	pure
CY2023	inbp	Effective Income Tax Rate Reconciliation Writeoff In Deferred Tax Assets Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationWriteoffInDeferredTaxAssetsValuationAllowancePercent	0.18	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.104	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.114	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Disposition Of Business EffectiveIncomeTaxRateReconciliationDispositionOfBusiness	0.184	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.006	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.126	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.584	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.34	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5032000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5105000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	678000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	678000	usd
CY2024Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	149000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	139000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	161000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	180000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	150000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Derivative Instruments DeferredTaxAssetsDerivativeInstruments	337000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1271000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1435000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4601000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4726000	usd
CY2024Q2	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2024Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2024	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	80000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	81000	usd
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2137000	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	1005000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	930000	usd
CY2024	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000	usd
CY2024	inbp	Finance Lease Expense FinanceLeaseExpense	12000	usd
CY2023	inbp	Finance Lease Expense FinanceLeaseExpense	12000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1790000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	945000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	846000	usd
CY2024Q2	inbp	Lease Commitment Amount LeaseCommitmentAmount	1905000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2623000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	888000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1735000	usd
CY2023Q2	inbp	Lease Commitment Amount LeaseCommitmentAmount	2830000	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	1061000	usd
CY2024	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2024	inbp	Repayments Of Long Term Capital Lease Obligations Including Interest RepaymentsOfLongTermCapitalLeaseObligationsIncludingInterest	42000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	989000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	usd
CY2023	inbp	Repayments Of Long Term Capital Lease Obligations Including Interest RepaymentsOfLongTermCapitalLeaseObligationsIncludingInterest	35000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	7000	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability Due Next Twelve Months LesseeOperatingAndFinanceLeaseLiabilityDueNextTwelveMonths	1018000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability To Be Paid Year Two LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearTwo	661000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability To Be Paid Year Three LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearThree	169000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability To Be Paid Year Four LesseeOperatingAndFinanceLeaseLiabilityToBePaidYearFour	64000	usd
CY2024Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7000	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability To Be Paid Total LesseeOperatingAndFinanceLeaseLiabilityToBePaidTotal	1912000	usd
CY2024Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	-0	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Liability Undiscounted Excess Amount LesseeOperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount	115000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	7000	usd
CY2024Q2	inbp	Lessee Operating And Finance Lease Total LesseeOperatingAndFinanceLeaseTotal	1797000	usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	6351818
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	129000	usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	461000	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4443933
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.36
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	527000
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.42
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	594649
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.46
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4376284
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.35
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	782500
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.27
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	150000
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.09
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18000
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.53
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	241601
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.44
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4749183
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3626551
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.3
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3804150
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.34
CY2024	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.09
CY2024	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	0.95
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4749183
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3804150
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.34
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	50317000	usd
CY2024	us-gaap	Gross Profit GrossProfit	3884000	usd
CY2024	us-gaap	Depreciation Depreciation	319000	usd
CY2024	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	553000	usd
CY2024Q2	us-gaap	Assets Assets	26207000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	50672000	usd
CY2023	us-gaap	Gross Profit GrossProfit	4061000	usd
CY2023	us-gaap	Depreciation Depreciation	351000	usd
CY2023	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	116000	usd
CY2023Q2	us-gaap	Assets Assets	25431000	usd

Files In Submission

Name	View Source	Status
0001437749-24-029768-index-headers.html	Edgar Link	pending
0001437749-24-029768-index.html	Edgar Link	pending
0001437749-24-029768.txt	Edgar Link	pending
0001437749-24-029768-xbrl.zip	Edgar Link	pending
ex_721278.htm	Edgar Link	pending
ex_721279.htm	Edgar Link	pending
ex_721280.htm	Edgar Link	pending
ex_721281.htm	Edgar Link	pending
ex_721282.htm	Edgar Link	pending
ex_721283.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inbp-20240630.xsd	Edgar Link	pending
inbp20240630_10k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
inbp-20240630_cal.xml	Edgar Link	unprocessable
inbp-20240630_def.xml	Edgar Link	unprocessable
inbp-20240630_lab.xml	Edgar Link	unprocessable
inbp-20240630_pre.xml	Edgar Link	unprocessable
inbp20240630_10k_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INBP
INTEGRATED BIOPHARMA INC Stock $inbp

2024 Q3 Form 10-K Financial Statement

#000143774924029768 Filed on September 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INBP INTEGRATED BIOPHARMA INC Stock $inbp

2024 Q3 Form 10-K Financial Statement

#000143774924029768 Filed on September 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INBP
INTEGRATED BIOPHARMA INC Stock $inbp